\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\,\\ mildly\\ tender\\ subcutaneous\\ mass\\ on\\ the\\ plantar\\ aspect\\ of\\ the\\ foot\\,\\ at\\ the\\ base\\ of\\ the\\ first\\ mtp\\ joint\\.\\ \\ mild\\ overlying\\ erythema\\.\\ otherwise\\ healthy\\ male\\.\\ \\ no\\ recallable\\ history\\ of\\ antecedent\\ trauma\\.\ \(0\)\
\-\ treatment\\ consists\\ of\\ wide\\ excision\\;\\ some\\ advocate\\ post\\ surgical\\ radiation\\ to\\ help\\ prevent\\ recurrence\\.\ \(0\)\
\-\ 2cm\\ x\\ 3cm\\ well\\-circumscribed\\ fusiform\\ mass\\ arising\\ from\\ the\\ plantar\\ fascia\\ on\\ the\\ medial\\ aspect\\ of\\ the\\ foot\\ proximal\\ to\\ the\\ 1st\\ mtp\\.\\ \\ lesion\\ is\\ homogenously\\ iso\\-intense\\ to\\ muscle\\ on\\ t1\\ sequences\\,\\ and\\ hetrogenslightly\\ hyperintense\\ on\\ fat\\-saturated\\ t2\\ sequences\\.\\ \\ marked\\,\\ homogeneous\\ enhancement\\ following\\ administration\\ of\\ gadolinium\\ dtpa\\.\\ \\ no\\ surrounding\\ soft\\ tissue\\ or\\ bone\\ marrow\\ edema\\.\ \(0\)\
\-\ plantar\\ fibromatosis\\ \\(ledderhose\\ disease\\)\ \(0\)\
\-\ plantar\\ fibromatosis\ \(1\)\
\-\ nodular\\ \\(pesudosarcomatous\\)fasciitis\ \(0\)\
\-\ aggressive\\ fibromatosis\ \(0\)\
\-\ enlarging\\ mass\\ on\\ medial\\ plantar\\ aspect\\ of\\ his\\ foot\\,\\ becomming\\ increasingly\\ sypmpomatic\\ over\\ last\\ 2\\ weeks\\.\ \(0\)\
\-\ location\\ and\\ imaging\\ characteristics\\ are\\ classic\\ for\\ this\\ entity\\ of\\ superficial\\ fibromatosis\\.\\ \\ nodular\\ fasciitis\\ is\\ a\\ differential\\ consideration\\,\\ but\\ only\\ involves\\ the\\ feet\\ in\\ \\~15\\%\\ of\\ cases\\,\\ being\\ mostly\\ found\\ in\\ the\\ upper\\ body\\ and\\ trunk\\.\\ \\ about\\ 50\\%\\ of\\ plantar\\ fibromas\\ are\\ painful\\.\\ \\ lesions\\ are\\ not\\ related\\ to\\ trauma\\ and\\ are\\ of\\ uncertain\\ etiology\\.\\ \\ lesions\\ can\\ be\\ bilateral\\ in\\ up\\ to\\ 50\\%\\ and\\ can\\ also\\ involve\\ the\\ palmar\\ fascia\\ \\(dupuytren\\'s\\ contracture\\)\\.\\ treatment\\ with\\ excision\\ must\\ include\\ the\\ entire\\ lesion\\,\\ and\\ similiar\\ to\\ other\\ fibromatoses\\,\\ lesions\\ tend\\ to\\ recurr\\.\\ \\ not\\ locally\\ destructive\\ as\\ the\\ deep\\ \\(aggressive\\)\\ fibromatoses\\(desmoid\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plantar\\:\\ 0\\.11015848401298133\ \(0\)\
\-\ fibromatosis\\:\\ 0\\.09287911420077051\ \(0\)\
\-\ fibromatoses\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ mtp\\:\\ 0\\.048252805647880655\ \(0\)\
\-\ fasciitis\\:\\ 0\\.04497973744293445\ \(0\)\
\-\ fascia\\:\\ 0\\.04270694893261164\ \(0\)\
\-\ foot\\:\\ 0\\.03983813566047191\ \(0\)\
\-\ recallable\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ hetrogenslightly\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ ledderhose\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ pesudosarcomatous\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ becomming\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ sypmpomatic\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ dupuytren\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ recurr\\:\\ 0\\.03314104670664097\ \(0\)\
\-\ aggressive\\:\\ 0\\.031434507035615504\ \(0\)\
\-\ \\~15\\:\\ 0\\.030535230238370497\ \(0\)\
\-\ aspect\\:\\ 0\\.030273969185902524\ \(0\)\
\-\ similiar\\:\\ 0\\.029010925320670632\ \(0\)\
\-\ advocate\\:\\ 0\\.027929413770100026\ \(0\)\
\-\ nodular\\:\\ 0\\.026950449677533166\ \(0\)\
\-\ sequences\\:\\ 0\\.026830784600045204\ \(0\)\
\-\ antecedent\\:\\ 0\\.02640510885240016\ \(0\)\
\-\ iso\\-intense\\:\\ 0\\.02640510885240016\ \(0\)\
\-\ excision\\:\\ 0\\.02637030621477664\ \(0\)\
\-\ contracture\\:\\ 0\\.0258255950184631\ \(0\)\
\-\ lesions\\:\\ 0\\.025799554582826477\ \(0\)\
\-\ fibromas\\:\\ 0\\.025323597301829554\ \(0\)\
\-\ homogenously\\:\\ 0\\.024880803934700293\ \(0\)\
\-\ 50\\:\\ 0\\.024443594110103793\ \(0\)\
\-\ fat\\-saturated\\:\\ 0\\.024126402823940327\ \(0\)\
\-\ palmar\\:\\ 0\\.02379929238412969\ \(0\)\
\-\ dtpa\\:\\ 0\\.023219778550192628\ \(0\)\
\-\ increasingly\\:\\ 0\\.023219778550192628\ \(0\)\
\-\ desmoid\\:\\ 0\\.022489868721467226\ \(0\)\
\-\ \\%\\:\\ 0\\.02248106428585723\ \(0\)\
\-\ locally\\:\\ 0\\.02207172723609044\ \(0\)\
\-\ 3cm\\:\\ 0\\.020892563480996298\ \(0\)\
\-\ 2cm\\:\\ 0\\.020750682548729957\ \(0\)\
\-\ medial\\:\\ 0\\.020551124162331215\ \(0\)\
\-\ trunk\\:\\ 0\\.020231320373990044\ \(0\)\
\-\ uncertain\\:\\ 0\\.020231320373990044\ \(0\)\
\-\ entity\\:\\ 0\\.019669170998159353\ \(0\)\
\-\ fusiform\\:\\ 0\\.01946591076781997\ \(0\)\
\-\ destructive\\:\\ 0\\.019273078834032186\ \(0\)\
\-\ 1st\\:\\ 0\\.018914769887399385\ \(0\)\
\-\ mostly\\:\\ 0\\.01874765799803535\ \(0\)\
\-\ tend\\:\\ 0\\.018215137257196905\ \(0\)\
\-\ consideration\\:\\ 0\\.017941605850120106\ \(0\)\
\-\ consists\\:\\ 0\\.017625503905719573\ \(0\)\
\-\ trauma\\:\\ 0\\.017571494599683674\ \(0\)\
\-\ are\\:\\ 0\\.017516900338791004\ \(0\)\
\-\ wide\\:\\ 0\\.01722335308033548\ \(0\)\
\-\ superficial\\:\\ 0\\.01716926008239526\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.01701149993540642\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.016714551020674723\ \(0\)\
\-\ feet\\:\\ 0\\.016439350253669854\ \(0\)\
\-\ enlarging\\:\\ 0\\.016351918441022236\ \(0\)\
\-\ help\\:\\ 0\\.016021208768293074\ \(0\)\
\-\ characteristics\\:\\ 0\\.01598184297931828\ \(0\)\
\-\ prevent\\:\\ 0\\.015942885133319984\ \(0\)\
\-\ erythema\\:\\ 0\\.01579096957565879\ \(0\)\
\-\ entire\\:\\ 0\\.01579096957565879\ \(0\)\
\-\ painful\\:\\ 0\\.01527040689045163\ \(0\)\
\-\ gadolinium\\:\\ 0\\.015238137177326097\ \(0\)\
\-\ homogeneous\\:\\ 0\\.01520614210338659\ \(0\)\
\-\ involve\\:\\ 0\\.01514295744806185\ \(0\)\
\-\ involves\\:\\ 0\\.014929817058300402\ \(0\)\
\-\ must\\:\\ 0\\.014644877812550274\ \(0\)\
\-\ can\\:\\ 0\\.014573100394504282\ \(0\)\
\-\ overlying\\:\\ 0\\.01453668621649748\ \(0\)\
\-\ healthy\\:\\ 0\\.01448373606656613\ \(0\)\
\-\ marrow\\:\\ 0\\.014132603829391691\ \(0\)\
\-\ recurrence\\:\\ 0\\.014014744694489151\ \(0\)\
\-\ last\\:\\ 0\\.013724558082868361\ \(0\)\
\-\ mildly\\:\\ 0\\.013681837185686725\ \(0\)\
\-\ on\\:\\ 0\\.013606973916643384\ \(0\)\
\-\ etiology\\:\\ 0\\.013597824784588994\ \(0\)\
\-\ \\(\\:\\ 0\\.01357822793691467\ \(0\)\
\-\ \\)\\:\\ 0\\.013412362633708742\ \(0\)\
\-\ mass\\:\\ 0\\.013403695567077795\ \(0\)\
\-\ hyperintense\\:\\ 0\\.01333706866504951\ \(0\)\
\-\ administration\\:\\ 0\\.01333706866504951\ \(0\)\
\-\ arising\\:\\ 0\\.013298510393744288\ \(0\)\
\-\ related\\:\\ 0\\.013260343583729184\ \(0\)\
\-\ lesion\\:\\ 0\\.013086881398499658\ \(0\)\
\-\ tender\\:\\ 0\\.013039138696424922\ \(0\)\
\-\ treatment\\:\\ 0\\.013004638793991632\ \(0\)\
\-\ deep\\:\\ 0\\.01300350432065596\ \(0\)\
\-\ base\\:\\ 0\\.012584429634704386\ \(0\)\
\-\ marked\\:\\ 0\\.012537140979791377\ \(0\)\
\-\ about\\:\\ 0\\.01238367483497839\ \(0\)\
\-\ classic\\:\\ 0\\.012309228867699518\ \(0\)\
\-\ otherwise\\:\\ 0\\.011538779073031372\ \(0\)\
\-\ muscle\\:\\ 0\\.011538779073031372\ \(0\)\
\-\ palpable\\:\\ 0\\.011385793393232296\ \(0\)\
\-\ to\\:\\ 0\\.011238634432710164\ \(0\)\
\-\ location\\:\\ 0\\.011205667995879296\ \(0\)\
\-\ being\\:\\ 0\\.011194691642107362\ \(0\)\
\-\ first\\:\\ 0\\.010780012912728768\ \(0\)\
\-\ cases\\:\\ 0\\.010702296481132077\ \(0\)\
\-\ x\\:\\ 0\\.010597993741907808\ \(0\)\
\-\ surrounding\\:\\ 0\\.01056077167054423\ \(0\)\
\-\ radiation\\:\\ 0\\.010542297930685474\ \(0\)\
\-\ body\\:\\ 0\\.010433322228154452\ \(0\)\
\-\ joint\\:\\ 0\\.010388831785872485\ \(0\)\
\-\ differential\\:\\ 0\\.010199097102830562\ \(0\)\
\-\ t1\\:\\ 0\\.010182314045955803\ \(0\)\
\-\ found\\:\\ 0\\.010124156445308693\ \(0\)\
\-\ post\\:\\ 0\\.01011592117696351\ \(0\)\
\-\ some\\:\\ 0\\.009755369375438944\ \(0\)\
\-\ only\\:\\ 0\\.009659442325131336\ \(0\)\
\-\ proximal\\:\\ 0\\.009644899179349681\ \(0\)\
\-\ not\\:\\ 0\\.009284350915352898\ \(0\)\
\-\ his\\:\\ 0\\.009258981306943352\ \(0\)\
\-\ \\,\\:\\ 0\\.009159363119005963\ \(0\)\
\-\ following\\:\\ 0\\.009117585552259956\ \(0\)\
\-\ weeks\\:\\ 0\\.009117585552259956\ \(0\)\
\-\ t2\\:\\ 0\\.00909243898026448\ \(0\)\
\-\ edema\\:\\ 0\\.009086178531696581\ \(0\)\
\-\ include\\:\\ 0\\.009011855218158973\ \(0\)\
\-\ up\\:\\ 0\\.008638523124263997\ \(0\)\
\-\ enhancement\\:\\ 0\\.008610860023018932\ \(0\)\
\-\ mild\\:\\ 0\\.008459599450868936\ \(0\)\
\-\ over\\:\\ 0\\.008179107481729182\ \(0\)\
\-\ bone\\:\\ 0\\.007982837148345375\ \(0\)\
\-\ soft\\:\\ 0\\.007823032947344172\ \(0\)\
\-\ bilateral\\:\\ 0\\.007796307253061819\ \(0\)\
\-\ upper\\:\\ 0\\.007752182351010219\ \(0\)\
\-\ \\;\\:\\ 0\\.007614365370122532\ \(0\)\
\-\ tissue\\:\\ 0\\.007614365370122532\ \(0\)\
\-\ imaging\\:\\ 0\\.007526593325021062\ \(0\)\
\-\ other\\:\\ 0\\.007404656198129506\ \(0\)\
\-\ \\'s\\:\\ 0\\.007082882023936259\ \(0\)\
\-\ 2\\:\\ 0\\.006917686077107316\ \(0\)\
\-\ but\\:\\ 0\\.006851516169299013\ \(0\)\
\-\ the\\:\\ 0\\.006756543989274944\ \(0\)\
\-\ surgical\\:\\ 0\\.006752713421997946\ \(0\)\
\-\ no\\:\\ 0\\.006469504892509789\ \(0\)\
\-\ also\\:\\ 0\\.0063331563671810195\ \(0\)\
\-\ male\\:\\ 0\\.005809043375516816\ \(0\)\
\-\ disease\\:\\ 0\\.005250893012089113\ \(0\)\
\-\ be\\:\\ 0\\.004953972644150109\ \(0\)\
\-\ as\\:\\ 0\\.004859313931932811\ \(0\)\
\-\ of\\:\\ 0\\.004817826348788995\ \(0\)\
\-\ from\\:\\ 0\\.004761036515617339\ \(0\)\
\-\ in\\:\\ 0\\.004752600339927687\ \(0\)\
\-\ history\\:\\ 0\\.004436896758297306\ \(0\)\
\-\ at\\:\\ 0\\.004352493055758019\ \(0\)\
\-\ is\\:\\ 0\\.00422775021341899\ \(0\)\
\-\ and\\:\\ 0\\.004060353512756807\ \(0\)\
\-\ or\\:\\ 0\\.003765123116404915\ \(0\)\
\-\ this\\:\\ 0\\.003613297794414034\ \(0\)\
\-\ for\\:\\ 0\\.002741008077604192\ \(0\)\
\-\ \\.\\:\\ 0\\.002268767344567243\ \(0\)\
\-\ a\\:\\ 0\\.0014909766985661702\ \(0\)\
\-\ with\\:\\ 0\\.00043986532364620197\ \(0\)\
